These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17312118)

  • 1. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
    Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
    J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of NKT cells.
    Bendelac A; Savage PB; Teyton L
    Annu Rev Immunol; 2007; 25():297-336. PubMed ID: 17150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
    Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
    J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.
    Lang GA; Illarionov PA; Glatman-Freedman A; Besra GS; Lang ML
    Int Immunol; 2005 Jul; 17(7):899-908. PubMed ID: 15967785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.
    Chen X; Wang X; Keaton JM; Reddington F; Illarionov PA; Besra GS; Gumperz JE
    J Immunol; 2007 May; 178(10):6181-90. PubMed ID: 17475845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.
    Yu ED; Girardi E; Wang J; Zajonc DM
    J Immunol; 2011 Sep; 187(5):2079-83. PubMed ID: 21810611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
    Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
    J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
    Halder RC; Aguilera C; Maricic I; Kumar V
    J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.